TCM Prescription: Hua Tuo Ointment



Prescription Description
Prescription IDTCMFx4846
Pinyin NameHua Tuo Gao
Chinese Name华佗膏
English NameHua Tuo Ointment
Function Description脚癣, 鹅掌风
IndicationsHand dampness itch disorder, Psoriasis, Dermatophytosis
Disease ICD-11 Category SB76 [Hand dampness itch disorder (TM1), 鹅掌风 (TM1) ];
EA90 [Psoriasis, 银屑病 ];
1F28 [Dermatophytosis, 足癣 ];
Human Tissues Associated with IndicationSkin
ReferenceCFDA
Reference Book/linkhttp://samr.cfda.gov.cn/WS01/CL0001/
Prescription Components
Component ID Latin Name Chinese Name Component Quantity Barcode
TCMH1237 NA 蜡梅油 TCMH1237
TCMH155 NA 苯甲酸 TCMH155
TCMH2585 Cinnamomum camphora 樟脑 TCMH2585 SDH069-14
TCMH2007 NA 水杨酸 TCMH2007
Reference: CFDA

Targeted Human Proteins by the Ingredients of Prescription

Target ID Gene Symbol Target Name Target Class Uniprot ID
TCMT154 PRKCD Protein kinase C delta Kinase Q05655


Targeted Pathogenic Microbes by the Ingredients of Prescription

Target ID Target Name
TCMT1175 Human immunodeficiency virus
TCMT1218 Staphylococcus aureus
TCMT1246 Escherichia coli
TCMT1251 Candida albicans
TCMT1253 Penicillium chrysogenum
TCMT1438 Plasmodium falciparum
TCMT1444 Fusarium oxysporum
TCMT1454 Bacillus subtilis
TCMT1455 Mycobacterium tuberculosis H37Rv
TCMT1462 Streptococcus mutans

Gene Ontology Associated to Targeted Human Proteins

GO Term GO Name Enriched Genes Log10 Adjusted P-value


KEGG Pathways Associated to Targeted Human Proteins

KEGG Pathway ID Enriched Genes Log10 Adjusted P-value


Target Exprsssion in Healthy Human Tissues (protein & mRNA level)

Protein expression data was from the "Human Proteome Map" dataset
mRNA expression data was from the "GTEx" dataset



Average Target Expression (Fold Change) in Multiple Disease Conditions

Fold Change with Corresponding Normal Samples
Click each cell within the heatmap to access gene expression of individual patient samples
Data Section
Select to Download
1. General Information of Prescription  
2. Putative Targets  
3. Activity & References for Filtering Putative Targets  
4. GO & Pathway